96 related articles for article (PubMed ID: 34404765)
1. LncRNA KCNQ1OT1 activated by c-Myc promotes cell proliferation via interacting with FUS to stabilize MAP3K1 in acute promyelocytic leukemia.
Tang D; Luo Y; Jiang Y; Hu P; Peng H; Wu S; Zhang G; Wang Y
Cell Death Dis; 2021 Aug; 12(9):795. PubMed ID: 34404765
[TBL] [Abstract][Full Text] [Related]
2. Exosomal HSPB1, interacting with FUS protein, suppresses hypoxia-induced ferroptosis in pancreatic cancer by stabilizing Nrf2 mRNA and repressing P450.
Zhang L; Yang L; Du K
J Cell Mol Med; 2024 May; 28(9):e18209. PubMed ID: 38682349
[TBL] [Abstract][Full Text] [Related]
3. FUS regulates the alternative splicing of cell proliferation genes related to atherosclerosis.
Hou J; Yang S; Guo Y; Yan N; Jia S
Exp Biol Med (Maywood); 2023 Sep; 248(17):1459-1468. PubMed ID: 37688506
[TBL] [Abstract][Full Text] [Related]
4. Recurrent noncoding somatic and germline WT1 variants converge to disrupt MYB binding in acute promyelocytic leukemia.
Song H; Liu Y; Tan Y; Zhang Y; Jin W; Chen L; Wu S; Yan J; Li J; Chen Z; Chen S; Wang K
Blood; 2022 Sep; 140(10):1132-1144. PubMed ID: 35653587
[TBL] [Abstract][Full Text] [Related]
5. Imprinted lncRNA KCNQ1OT1 regulates CDKN1C expression through promoter binding and chromatin folding in pigs.
Zhou Y; Yu H; Zhang D; Wang Z; Li Q; An X; Zhang S; Li Z
Gene; 2024 May; 923():148590. PubMed ID: 38772516
[TBL] [Abstract][Full Text] [Related]
6. STAT3/LINC00671 axis regulates papillary thyroid tumor growth and metastasis via LDHA-mediated glycolysis.
Huo N; Cong R; Sun ZJ; Li WC; Zhu X; Xue CY; Chen Z; Ma LY; Chu Z; Han YC; Kang XF; Jia SH; Du N; Kang L; Xu XJ
Cell Death Dis; 2021 Aug; 12(9):799. PubMed ID: 34404767
[TBL] [Abstract][Full Text] [Related]
7. LncRNA SNHG17 regulates cell proliferation and invasion by targeting miR-338-3p/SOX4 axis in esophageal squamous cell carcinoma.
Chen W; Wang L; Li X; Zhao C; Shi L; Zhao H; Huang C
Cell Death Dis; 2021 Aug; 12(9):806. PubMed ID: 34429400
[TBL] [Abstract][Full Text] [Related]
8. MIR22HG inhibits breast cancer progression by stabilizing LATS2 tumor suppressor.
Deng X; Ye D; Hua K; Song H; Luo Q; Munankarmy A; Liu D; Zhou B; Zheng W; Zhou X; Ji C; Wang X; Yu Y; Fang L
Cell Death Dis; 2021 Aug; 12(9):810. PubMed ID: 34446703
[TBL] [Abstract][Full Text] [Related]
9. USP14 maintains HIF1-α stabilization via its deubiquitination activity in hepatocellular carcinoma.
Lv C; Wang S; Lin L; Wang C; Zeng K; Meng Y; Sun G; Wei S; Liu Y; Zhao Y
Cell Death Dis; 2021 Aug; 12(9):803. PubMed ID: 34420039
[TBL] [Abstract][Full Text] [Related]
10. LncRNA ZNFTR functions as an inhibitor in pancreatic cancer by modulating ATF3/ZNF24/VEGFA pathway.
Li W; Han S; Hu P; Chen D; Zeng Z; Hu Y; Xu F; Tang J; Wang F; Zhao Y; Huang M; Zhao G
Cell Death Dis; 2021 Sep; 12(9):830. PubMed ID: 34480024
[TBL] [Abstract][Full Text] [Related]
11. Sirt1 deficiency upregulates glutathione metabolism to prevent hepatocellular carcinoma initiation in mice.
Qiu P; Hou W; Wang H; Lei KKW; Wang S; Chen W; Pardeshi LA; Prothro K; Shukla Y; Su SSM; Schrump DS; Chen Q; Deng CX; Xu X; Wang R
Oncogene; 2021 Oct; 40(41):6023-6033. PubMed ID: 34433910
[TBL] [Abstract][Full Text] [Related]
12. TMED3 promotes the progression and development of lung squamous cell carcinoma by regulating EZR.
Xie A; Xu X; Kuang P; Zhang L; Yu F
Cell Death Dis; 2021 Aug; 12(9):804. PubMed ID: 34429402
[TBL] [Abstract][Full Text] [Related]
13. miR-26a enhances colorectal cancer cell growth by targeting RREB1 deacetylation to activate AKT-mediated glycolysis.
Chen B; Deng YN; Wang X; Xia Z; He Y; Zhang P; Syed SE; Li Q; Liang S
Cancer Lett; 2021 Aug; 521():1-13. PubMed ID: 34419497
[TBL] [Abstract][Full Text] [Related]
14. RIPK3 activation induces TRIM28 derepression in cancer cells and enhances the anti-tumor microenvironment.
Park HH; Kim HR; Park SY; Hwang SM; Hong SM; Park S; Kang HC; Morgan MJ; Cha JH; Lee D; Roe JS; Kim YS
Mol Cancer; 2021 Aug; 20(1):107. PubMed ID: 34419074
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive Characterization of RNA Processing Factors in Gastric Cancer Identifies a Prognostic Signature for Predicting Clinical Outcomes and Therapeutic Responses.
Lou S; Meng F; Yin X; Zhang Y; Han B; Xue Y
Front Immunol; 2021; 12():719628. PubMed ID: 34413861
[TBL] [Abstract][Full Text] [Related]
16. LncRNA coordinates Hippo and mTORC1 pathway activation in cancer.
Zhang S; Liang S; Wu D; Guo H; Ma K; Liu L
Cell Death Dis; 2021 Aug; 12(9):822. PubMed ID: 34462427
[TBL] [Abstract][Full Text] [Related]
17. CircHIPK3 relieves vascular calcification via mediating SIRT1/PGC-1α/MFN2 pathway by interacting with FUS.
Feng S; Qi Y; Xiao Z; Chen H; Liu S; Luo H; Wu H; Zhang W
BMC Cardiovasc Disord; 2023 Nov; 23(1):583. PubMed ID: 38012555
[TBL] [Abstract][Full Text] [Related]
18. Long non coding RNAs reveal important pathways in childhood asthma: a future perspective.
Goodarzi V; Nouri S; Nassaj ZS; Bighash M; Abbasian S; Hagh RA
J Mol Histol; 2023 Aug; 54(4):257-269. PubMed ID: 37537509
[TBL] [Abstract][Full Text] [Related]
19. Upregulation and the clinical significance of KCNQ1OT1 and HAGLROS lncRNAs in papillary thyroid cancer: An observational study.
Mutlu Icduygu F; Akgun E; Ozgoz A; Hekimler Ozturk K; Sengul D; Alp E
Medicine (Baltimore); 2023 Jul; 102(29):e34379. PubMed ID: 37478216
[TBL] [Abstract][Full Text] [Related]
20. Roles of non-coding RNAs in the metabolism and pathogenesis of bladder cancer.
Sanya DRA; Onésime D
Hum Cell; 2023 Jul; 36(4):1343-1372. PubMed ID: 37209205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
